Lei Yu

机构：Ministry of Education of the People's Republic of China, Jilin University, Fudan University, Guangzhou University, Fudan University Shanghai Cancer Center, Shanghai Genon Biological Products (China), Zhongshan Hospital, Central Hospital of Wuhan, Wuhan General Hospital of Guangzhou, Dalian Maritime University, Huazhong University of Science and Technology · ORCID：0000-0002-1083-0361

发表论文 146 篇 · 总被引 4188 次 · h-index 39

代表论文

• Remodeling liver microenvironment by L-arginine loaded hollow polydopamine nanoparticles for liver cirrhosis treatment (2023 · Biomaterials · 被引 51)
• Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells (2023 · Frontiers in Immunology · 被引 34)
• Tandem bispecific CD123 / CLL ‐1 CAR‐T cells exhibit specific cytolytic effector functions against human acute myeloid leukaemia (2023 · European Journal Of Haematology · 被引 25)
• CD19 CAR-T in relapsed t(8;21) AML: a single-center prospective phase II clinical trial (2025 · Journal of Hematology & Oncology · 被引 19)
• Tislelizumab augment the efficacy of CD19/22 dual‐targeted chimeric antigen receptor T cell in advanced stage relapsed or refractory B‐cell non‐Hodgkin lymphoma (2023 · Hematological Oncology · 被引 13)
• Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion (2024 · Cellular Oncology · 被引 9)